Clinical Trial Update: An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin [Phase 4]

View source ↗

Summary

Phase 4 trial comparing canagliflozin and sitagliptin to assess glucose variability in Mexican participants with type 2 diabetes inadequately controlled on metf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)
• Januvia (sitagliptin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2019-11-29